DKSH among bidders vying to acquire Swiss drug distributor Swixx Biopharma, people familiar with matter say. Business valued at around €1.5 billion (US$1.7 billion) to €2 billion in potential deal.
DKSH Holding AG, the Zurich-based distribution firm, is among bidders vying to acquire Swiss drug distribution company Swixx Biopharma SA, according to people familiar with the matter. Swixx has also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback